Application of stem cells for cardiovascular grafts tissue engineering

Transplant Immunology

Volumn 16, Issue 1, 2006, Pages 1-7

  Wu, Kaihong ^a   Liu, Ying Long ^a   Cui, Bin ^a   Han, Zhongchao ^b  

^a FUWAI HOSPITAL   (China)

^b INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

Author keywords

Autologous; Cardiovascular; Stem cells; Tissue engineering

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; BIOMATERIAL; BIOMIMETIC MATERIAL; POLYGLACTIN; POLYGLYCOLIC ACID; POLYLACTIC ACID; POLYLACTIDE; POLYMER; VASCULOTROPIN;

BIOENGINEERING; BLOOD VESSEL GRAFT; CARDIOVASCULAR SURGERY; CELL ADHESION; CELL DIFFERENTIATION; CELL GROWTH; CELL ISOLATION; CELL LINEAGE; CELL PROLIFERATION; CELL SUBPOPULATION; CELL TYPE; ENDOTHELIUM CELL; HEART GRAFT; HEART MUSCLE CELL; HEART VALVE; HEART VALVE REPLACEMENT; HEMATOPOIETIC STEM CELL; HUMAN; MESENCHYMAL STEM CELL; MULTIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; SENESCENCE; STEM CELL; TISSUE CULTURE; TISSUE ENGINEERING; TISSUE GROWTH; VASCULARIZATION;

ANIMALS; CARDIOVASCULAR SURGICAL PROCEDURES; HUMANS; PROSTHESES AND IMPLANTS; STEM CELLS; TISSUE ENGINEERING;

EID: 33646515746     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2006.03.004     Document Type: Review

References (58)

1. Zhu X., Shang H., Yu C., Liu Y., and Du M. Pediatric cardiac surgery in China. Chin Med J (Engl) 112 (1999) 892-896
2. Lange R., Weipert J., Homann M., et al. Performance of allografts and xenografts for right ventricular outflow tract reconstruction. Ann Thorac Surg 71 (2001) S365-S367
3. Allen B.S., El-Zein C., Cuneo B., Cava J.P., Barth M.J., and Ilbawi M.N. Pericardial tissue valves and Gore-Tex conduits as an alternative for right ventricular outflow tract replacement in children. Ann Thorac Surg 74 (2002) 771-777
4. Dave H.H., Kadner A., Berger F., et al. Early results of the bovine jugular vein graft used for reconstruction of the right ventricular outflow tract. Ann Thorac Surg 79 (2005) 618-624
5. Selamet Tierney E.S., Gersony W.M., Altmann K., et al. Pulmonary position cryopreserved homografts: durability in pediatric Ross and non-Ross patients. J Thorac Cardiovasc Surg 130 (2005) 282-286
6. Langer R., and Vacanti J.P. Tissue engineering. Science 260 (1993) 920-926
7. Shinoka T., Shum-Tim D., Ma P.X., et al. Creation of viable pulmonary artery autografts through tissue engineering. J Thorac Cardiovasc Surg 115 (1998) 536-545 [discussion 545-536]
8. Shin'oka T., Imai Y., and Ikada Y. Transplantation of a tissue-engineered pulmonary artery. N Engl J Med 344 (2001) 532-533
9. Zimmermann W.H., Schneiderbanger K., Schubert P., et al. Tissue engineering of a differentiated cardiac muscle construct. Circ Res 90 (2002) 223-230
10. Wollert K.C., and Drexler H. Clinical applications of stem cells for the heart. Circ Res 96 (2005) 151-163
11. Makino S., Fukuda K., Miyoshi S., et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 103 (1999) 697-705
12. Pittenger M.F., Mackay A.M., Beck S.C., et al. Multilineage potential of adult human mesenchymal stem cells. Science 284 (1999) 143-147
13. Hakuno D., Fukuda K., Makino S., et al. Bone marrow-derived regenerated cardiomyocytes (CMG Cells) express functional adrenergic and muscarinic receptors. Circulation 105 (2002) 380-386
14. Kocher A.A., Schuster M.D., Szabolcs M.J., et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7 (2001) 430-436
15. Urbich C., Heeschen C., Aicher A., Dernbach E., Zeiher A.M., and Dimmeler S. Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells. Circulation 108 (2003) 2511-2516
16. Shirota T., Yasui H., Shimokawa H., and Matsuda T. Fabrication of endothelial progenitor cell (EPC)-seeded intravascular stent devices and in vitro endothelialization on hybrid vascular tissue. Biomaterials 24 (2003) 2295-2302
17. Hristov M., Erl W., and Weber P.C. Endothelial progenitor cells: mobilization, differentiation, and homing. Arterioscler Thromb Vasc Biol 23 (2003) 1185-1189
18. Barry F.P., and Murphy J.M. Mesenchymal stem cells: clinical applications and biological characterization. Int J Biochem Cell Biol 36 (2004) 568-584
19. Jiang Y., Jahagirdar B.N., Reinhardt R.L., et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418 (2002) 41-49
20. D'Ippolito G., Diabira S., Howard G.A., Menei P., Roos B.A., and Schiller P.C. Marrow-isolated adult multilineage inducible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential. J Cell Sci 117 (2004) 2971-2981
21. Yoon Y.S., Wecker A., Heyd L., et al. Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. J Clin Invest 115 (2005) 326-338
22. Zuk P.A., Zhu M., Ashjian P., et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13 (2002) 4279-4295
23. Planat-Benard V., Menard C., Andre M., et al. Spontaneous cardiomyocyte differentiation from adipose tissue stroma cells. Circ Res 94 (2004) 223-229
24. Planat-Benard V., Silvestre J.S., Cousin B., et al. Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation 109 (2004) 656-663
25. Romanov Y.A., Svintsitskaya V.A., and Smirnov V.N. Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord. Stem Cells 21 (2003) 105-110
26. Lee O.K., Kuo T.K., Chen W.M., Lee K.D., Hsieh S.L., and Chen T.H. Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 103 (2004) 1669-1675
27. Kadivar M., Khatami S., Mortazavi Y., Shokrgozar M.A., Taghikhani M., and Soleimani M. In vitro cardiomyogenic potential of human umbilical vein-derived mesenchymal stem cells. Biochem Biophys Res Commun 340 (2006) 639-647
28. Chen G., Ushida T., and Tateishi T. A biodegradable hybrid sponge nested with collagen microsponges. J Biomed Mater Res 51 (2000) 273-279
29. Ozawa T., Mickle D.A., Weisel R.D., Koyama N., Ozawa S., and Li R.K. Optimal biomaterial for creation of autologous cardiac grafts. Circulation 106 (2002) I176-I182
30. Iwai S., Sawa Y., Ichikawa H., et al. Biodegradable polymer with collagen microsponge serves as a new bioengineered cardiovascular prosthesis. J Thorac Cardiovasc Surg 128 (2004) 472-479
31. Zimmermann W.H., Melnychenko I., and Eschenhagen T. Engineered heart tissue for regeneration of diseased hearts. Biomaterials 25 (2004) 1639-1647
32. Shimizu T., Yamato M., Kikuchi A., and Okano T. Cell sheet engineering for myocardial tissue reconstruction. Biomaterials 24 (2003) 2309-2316
33. Dar A., Shachar M., Leor J., and Cohen S. Optimization of cardiac cell seeding and distribution in 3D porous alginate scaffolds. Biotechnol Bioeng 80 (2002) 305-312
34. Godbey W.T., Hindy S.B., Sherman M.E., and Atala A. A novel use of centrifugal force for cell seeding into porous scaffolds. Biomaterials 25 (2004) 2799-2805
35. Barron V., Lyons E., Stenson-Cox C., McHugh P.E., and Pandit A. Bioreactors for cardiovascular cell and tissue growth: a review. Ann Biomed Eng 31 (2003) 1017-1030
36. Kofidis T., Akhyari P., Boublik J., et al. In vitro engineering of heart muscle: artificial myocardial tissue. J Thorac Cardiovasc Surg 124 (2002) 63-69
37. Akhyari P., Fedak P.W., Weisel R.D., et al. Mechanical stretch regimen enhances the formation of bioengineered autologous cardiac muscle grafts. Circulation 106 (2002) I137-I142
38. Birla R.K., Borschel G.H., and Dennis R.G. In vivo conditioning of tissue-engineered heart muscle improves contractile performance. Artif Organs 29 (2005) 866-875
39. Perets A., Baruch Y., Weisbuch F., Shoshany G., Neufeld G., and Cohen S. Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres. J Biomed Mater Res A 65 (2003) 489-497
40. Richardson T.P., Peters M.C., Ennett A.B., and Mooney D.J. Polymeric system for dual growth factor delivery. Nat Biotechnol 19 (2001) 1029-1034
41. Li R.K., Jia Z.Q., Weisel R.D., Mickle D.A., Choi A., and Yau T.M. Survival and function of bioengineered cardiac grafts. Circulation 100 (1999) II63-II69
42. Leor J., Aboulafia-Etzion S., Dar A., et al. Bioengineered cardiac grafts: a new approach to repair the infarcted myocardium?. Circulation 102 (2000) III56-III61
43. Pasumarthi K.B., and Field L.J. Cardiomyocyte cell cycle regulation. Circ Res 90 (2002) 1044-1054
44. Laugwitz K.L., Moretti A., Lam J., et al. Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 433 (2005) 647-653
45. Xaymardan M., Tang L., Zagreda L., et al. Platelet-derived growth factor-AB promotes the generation of adult bone marrow-derived cardiac myocytes. Circ Res 94 (2004) E39-E45
46. Passier R., Oostwaard D.W., Snapper J., et al. Increased cardiomyocyte differentiation from human embryonic stem cells in serum-free cultures. Stem Cells 23 (2005) 772-780
47. Harada M., Itoh H., Nakagawa O., et al. Significance of ventricular myocytes and nonmyocytes interaction during cardiocyte hypertrophy: evidence for endothelin-1 as a paracrine hypertrophic factor from cardiac nonmyocytes. Circulation 96 (1997) 3737-3744
48. Vats A., Bielby R.C., Tolley N.S., Nerem R., and Polak J.M. Stem cells. Lancet 366 (2005) 592-602
49. Hoerstrup S.P., Kadner A., Melnitchouk S., et al. Tissue engineering of functional trileaflet heart valves from human marrow stromal cells. Circulation 106 (2002) I143-I150
50. Perry T.E., Kaushal S., Sutherland F.W., et al. Thoracic Surgery Directors Association Award. Bone marrow as a cell source for tissue engineering heart valves. Ann Thorac Surg 75 (2003) 761-767 [discussion 767]
51. Knight R.L., Booth C., Wilcox H.E., Fisher J., and Ingham E. Tissue engineering of cardiac valves: re-seeding of acellular porcine aortic valve matrices with human mesenchymal progenitor cells. J Heart Valve Dis 14 (2005) 806-813
52. Sutherland F.W., Perry T.E., Yu Y., et al. From stem cells to viable autologous semilunar heart valve. Circulation 111 (2005) 2783-2791
53. Meinhart J.G., Deutsch M., Fischlein T., Howanietz N., Froschl A., and Zilla P. Clinical autologous in vitro endothelialization of 153 infrainguinal ePTFE grafts. Ann Thorac Surg 71 (2001) S327-S331
54. Hoerstrup S.P., Kadner A., Breymann C., et al. Living, autologous pulmonary artery conduits tissue engineered from human umbilical cord cells. Ann Thorac Surg 74 (2002) 46-52 [discussion 52]
55. Schmidt D., Breymann C., Weber A., et al. Umbilical cord blood derived endothelial progenitor cells for tissue engineering of vascular grafts. Ann Thorac Surg 78 (2004) 2094-2098
56. Schmidt D., Mol A., Neuenschwander S., et al. Living patches engineered from human umbilical cord derived fibroblasts and endothelial progenitor cells. Eur J Cardiothorac Surg 27 (2005) 795-800
57. Matsumura G., Miyagawa-Tomita S., Shin'oka T., Ikada Y., and Kurosawa H. First evidence that bone marrow cells contribute to the construction of tissue-engineered vascular autografts in vivo. Circulation 108 (2003) 1729-1734
58. Shin'oka T., Matsumura G., Hibino N., et al. Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells. J Thorac Cardiovasc Surg 129 (2005) 1330-1338